alpha-2c adrenoreceptor antagonist (Juvantia/Orion)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namealpha-2c adrenoreceptor antagonist (Juvantia/Orion)
Drug Alias NameJP-1514
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-2c adrenergic receptor antagonists
TargetsAlpha-2c adrenergic receptor
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJuvantia Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A